P22455 (FGFR4_HUMAN) Homo sapiens (Human)

Fibroblast growth factor receptor 4 UniProtKBInterProSTRINGInteractive Modelling

802 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

45 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Cryo-EM Structure of FGF23-FGFR4-aKlotho-HS Quaternary Complex Heteromer
Q9GZV9; Q9UEF7;
142-354
IDS;CU;ZN;
Assess
Crystal structure of FGFR4 domain 3 in complex with a de novo-designed mini-binder Heteromer
245-353
Assess
Crystal structure of FGFR4 domain 3 in complex with a de novo-designed mini-binder in P21 space gro… Heteromer
246-353
Assess
FGFR4 D2 - Fab complex Heteromer
143-243
Assess
Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinasemonomer447-753
0LI;EDO;PO4;
Assess
Crystal Structure of FGF Receptor (FGFR) 4 Kinase Harboring the V550L Gate-Keeper Mutation in Compl…monomer445-750
37O;
Assess
Crystal structure of FGFR4 kinase domain in complex with a covalent inhibitormonomer445-750
AWX;
Assess
Crystal Structure of FGF Receptor (FGFR) 4 Kinase Harboring the V550L Gate-Keeper Mutation in Compl…monomer445-750
FI3;SO4;
Assess
Crystal Structure of FGF Receptor (FGFR) 4 Kinase Domain in Complex with FIIN-2, an Irreversible Ty…monomer445-750
37O;SO4;
Assess
Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinasemonomer447-751
ACT;
Assess
Structural analysis of the human Fibroblast Growth Factor Receptor 4monomer447-750
38O;
Assess
Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinasemonomer451-753
PO4;
Assess
HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIBmonomer453-753
FGF;SO4;
Assess
Crystal structure of FGFR4 kinase domain with PRN1371monomer453-753
GX3;SO4;
Assess
FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA…monomer453-753
99K;
Assess
Crystal structure of FGFR4 kinase domain with irreversible inhibitor 1monomer452-751
BYU;SO4;
Assess
Crystal structure of FGFR4 kinase domain with 10tmonomer453-752
IIW;SO4;GOL;
Assess
Crystal structure of FGFR4 kinase domain with 7vmonomer453-752
90F;SO4;GOL;
Assess
Crystal structure of FGFR4(V550M) kinase domain with 7vmonomer453-752
90F;SO4;
Assess
Crystal structure of FGFR4(V550M) kinase domain with 10zmonomer453-752
IH7;SO4;
Assess
Crystal structure of FGFR4(V550L) kinase domain with 10zmonomer453-752
IH7;SO4;
Assess
Crystal structure of FGFR4 kinase domain with 10zmonomer453-752
IH7;SO4;
Assess
Crystal structure of FGFR4(V550L) kinase domain with 7vmonomer453-752
90F;SO4;
Assess
Crystal structure of FGFR4 kinase domain with 10dmonomer453-752
IIQ;SO4;GOL;
Assess
The crystal structure of FGFR4 kinase domain in complex with N-(5-cyano-4-((2-methoxyethyl)amino)py…monomer454-753
7IF;
Assess
Crystal Structure of FGF Receptor (FGFR) 4 Kinase Domain Harboring the V550L Gate-Keeper Mutationmonomer454-752
SO4;
Assess
Crystal Structure of FGFR4 with an Irreversible Inhibitormonomer453-751
SO4;40M;
Assess
FGFR4 in complex with Ponatinibmonomer452-750
SO4;0LI;
Assess
Crystal structure of FGFR4 kinase domain in complex with covalent inhibitormonomer453-751
QS7;SO4;
Assess
FGFR4 kinase domain with a dual-warhead covalent inhibitor CXF-007monomer453-751
A1LVQ;SO4;
Assess
FGFR4 complex with N-(3,5-dichloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amin…monomer453-751
SO4;XL8;
Assess
Crystal structure of FGFR4 kinase domain in complex with compound 5monomer452-750
AX0;DMS;
Assess
FGFR4 complex with a covalent inhibitormonomer453-751
HHL;SO4;
Assess
FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-fluoroph…monomer453-751
SO4;XL5;
Assess
FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA…monomer454-752
9CT;
Assess
Crystal structure of FGF401 in complex of FGFR4monomer454-752
FGF;SO4;
Assess
FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylph…monomer453-750
SO4;XL6;
Assess
FGFR4 complex with N-(3-chloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-5…monomer453-750
XL7;SO4;
Assess
FGFR4 complex with BLU-554, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amin…monomer453-750
SO4;XL9;
Assess
The crystal structure of FGFR4 kinase domain in complex with LY2874455monomer453-750
6LF;
Assess
Crystal structure of LY2874455 in complex of FGFR4 gatekeeper mutation (V550L)monomer453-750
6LF;
Assess
Crystal structure of LY2874455 in complex of FGFR4 gatekeeper mutation (V550M)monomer453-750
6LF;
Assess
Crystal Structure of FGF Receptor (FGFR) 4 Tyrosine Kinase Domainmonomer454-750
SO4;
Assess
Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 4 in Complex with Ponatinibmonomer454-750
SO4;0LI;
Assess
Crystal structure of FGFR4 with a dual-warhead covalent inhhibitormonomer454-750
5JR;SO4;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5a46.1.Amonomer0.76453-749
74.52
Assess
1ry7.1.Bmonomer0.61146-355
60.45
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25a46.1.Amonomer0.76413-709
74.53
Assess
Isoform 21ry7.1.Bmonomer0.63146-356
58.44
Assess